Benefit of Ezetimibe Added to Simvastatin in Reduced Kidney Function

Por Stanifer, John W., Charytan, David M., White, Jennifer, Lokhnygina, Yuliya, Cannon, Christopher P., Roe, Matthew T., Blazing, Michael A.
Publicado no J Am Soc Nephrol (2017)

Competing Risks of Cardiovascular Versus Noncardiovascular Death During Long‐Term Follow‐Up After Acute Coronary Syndromes

Por Fanaroff, Alexander C., Roe, Matthew T., Clare, Robert M., Lokhnygina, Yuliya, Navar, Ann Marie, Giugliano, Robert P., Wiviott, Stephen D., Tershakovec, Andrew M., Braunwald, Eugene, Blazing, Michael A.
Publicado no J Am Heart Assoc (2017)

Efficacy and Safety of Adding Ezetimibe to Statin Therapy Among Women and Men: Insight From IMPROVE‐IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)

Por Kato, Eri Toda, Cannon, Christopher P., Blazing, Michael A., Bohula, Erin, Guneri, Sema, White, Jennifer A., Murphy, Sabina A., Park, Jeong‐Gun, Braunwald, Eugene, Giugliano, Robert P.
Publicado no J Am Heart Assoc (2017)

Acute Decline in Renal Function, Inflammation, and Cardiovascular Risk after an Acute Coronary Syndrome

Por Mielniczuk, Lisa M., Pfeffer, Marc A., Lewis, Eldrin F., Blazing, Michael A., de Lemos, James A., Mohanavelu, Satishkumar, Rouleau, Jean, Fox, Keith, Pedersen, Terje R., Califf, Robert M.
Publicado em 2009

Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial

Por Tricoci, Pierluigi, D’Andrea, Denise M, Gurbel, Paul A, Yao, Zhenling, Cuchel, Marina, Winston, Brion, Schott, Robert, Weiss, Robert, Blazing, Michael A, Cannon, Louis, Bailey, Alison, Angiolillo, Dominick J, Gille, Andreas, Shear, Charles L, Wright, Samuel D, Alexander, John H
Publicado no J Am Heart Assoc (2015)